Surgery Partners, Inc. (SGRY)
NASDAQ: SGRY · Real-Time Price · USD
14.35
-0.19 (-1.31%)
At close: Apr 28, 2026, 4:00 PM EDT
14.20
-0.15 (-1.05%)
After-hours: Apr 28, 2026, 6:33 PM EDT
Surgery Partners Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Surgery Partners stock have an average target of 22.25, with a low estimate of 14 and a high estimate of 36. The average target predicts an increase of 55.05% from the current stock price of 14.35.
Analyst Consensus: Buy
* Price targets were last updated on Mar 5, 2026.
Analyst Ratings
The average analyst rating for Surgery Partners stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Hold | 3 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 8 | 8 | 8 | 9 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy Maintains $28 → $20 | Strong Buy | Maintains | $28 → $20 | +39.37% | Mar 5, 2026 |
| UBS | UBS | Strong Buy Maintains $29 → $21 | Strong Buy | Maintains | $29 → $21 | +46.34% | Mar 5, 2026 |
| Mizuho | Mizuho | Buy Maintains $19 → $17 | Buy | Maintains | $19 → $17 | +18.47% | Mar 5, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $31 → $20 | Buy | Maintains | $31 → $20 | +39.37% | Mar 4, 2026 |
| Barclays | Barclays | Hold Maintains $18 → $14 | Hold | Maintains | $18 → $14 | -2.44% | Mar 3, 2026 |
Financial Forecast
Revenue This Year
3.48B
from 3.31B
Increased by 5.09%
Revenue Next Year
3.67B
from 3.48B
Increased by 5.67%
EPS This Year
0.24
from -0.61
EPS Next Year
0.45
from 0.24
Increased by 85.42%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 3.6B | 4.0B | ||
| Avg | 3.5B | 3.7B | ||
| Low | 3.3B | 3.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 9.9% | 13.7% | ||
| Avg | 5.1% | 5.7% | ||
| Low | -0.6% | -0.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 0.61 | 0.89 | ||
| Avg | 0.24 | 0.45 | ||
| Low | -0.17 | 0.06 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | - | 264.6% | ||
| Avg | - | 85.4% | ||
| Low | - | -76.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.